Conflicts of Interest Among Infectious Diseases Clinical Practice Guideline Authors and the Pharmaceutical Industry

This cross-sectional study assesses the prevalence of conflicts of interest (COI) associated with guideline-recommended drugs among Infectious Diseases Society of America clinical practice guideline authors and compliance with the Council on Medical Specialty Societies and Institute of Medicine guid...

Full description

Saved in:
Bibliographic Details
Published in:JAMA network open 2023-04, Vol.6 (4), p.e238592-e238592
Main Authors: Ahiskali, Aileen S, Drekonja, Dimitri M, Alpern, Jonathan D
Format: Article
Language:English
Subjects:
Conflict of Interest
Drug Industry
Humans
Infectious Diseases
Medicine
Online Only
Research Letter
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-a471t-e734952fff2081059fc982b43702277f458de42a98e01d178f4a517decca07a53
cites cdi_FETCH-LOGICAL-a471t-e734952fff2081059fc982b43702277f458de42a98e01d178f4a517decca07a53
container_end_page e238592
container_issue 4
container_start_page e238592
container_title JAMA network open
container_volume 6
creator Ahiskali, Aileen S
Drekonja, Dimitri M
Alpern, Jonathan D
description This cross-sectional study assesses the prevalence of conflicts of interest (COI) associated with guideline-recommended drugs among Infectious Diseases Society of America clinical practice guideline authors and compliance with the Council on Medical Specialty Societies and Institute of Medicine guidelines.
doi_str_mv 10.1001/jamanetworkopen.2023.8592
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10111177</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2802423284</sourcerecordid><originalsourceid>FETCH-LOGICAL-a471t-e734952fff2081059fc982b43702277f458de42a98e01d178f4a517decca07a53</originalsourceid><addsrcrecordid>eNpdUU1PXCEUJU2baqx_ocF0082MfApvZSZj1UlM6qJdE-RdHKbvwRR4Nv57Gb9iZQOXe87JvecgdETJnBJCjzd2tBHqv5T_pC3EOSOMz7Xs2Ae0z6QSM66J_PjmvYcOS9kQQhihvDuRn9EeV-REacL2UVmm6IfgasHJ41WskKFUvBhTvG2lB1dDmgo-CwVsgYKXQ4jB2QFfZ9t6DvDFFHpov4AXU12nXLCNPa5rwNdrm0frYKqPjFXsp1Lz_Rf0yduhwOHzfYB-n__4tbycXf28WC0XVzMrFK0zUFx0knnvGdGUyM67TrMb0YZnTCkvpO5BMNtpILSnSnthJVU9OGeJspIfoNMn3e10M0LvINZsB7PNYbT53iQbzP-dGNbmNt0ZSmg7SjWF788KOf2dmjFmDMXBMLQEmiuGNQ8F40yLBv32DrpJU45tP8Mp14IqqWhDdU8ol1MpGfzrNJSYXbzmXbxmF6_Zxdu4X9-u88p8CZM_AEsgp7g</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3138417571</pqid></control><display><type>article</type><title>Conflicts of Interest Among Infectious Diseases Clinical Practice Guideline Authors and the Pharmaceutical Industry</title><source>Publicly Available Content Database (Proquest) (PQ_SDU_P3)</source><creator>Ahiskali, Aileen S ; Drekonja, Dimitri M ; Alpern, Jonathan D</creator><creatorcontrib>Ahiskali, Aileen S ; Drekonja, Dimitri M ; Alpern, Jonathan D</creatorcontrib><description>This cross-sectional study assesses the prevalence of conflicts of interest (COI) associated with guideline-recommended drugs among Infectious Diseases Society of America clinical practice guideline authors and compliance with the Council on Medical Specialty Societies and Institute of Medicine guidelines.</description><identifier>ISSN: 2574-3805</identifier><identifier>EISSN: 2574-3805</identifier><identifier>DOI: 10.1001/jamanetworkopen.2023.8592</identifier><identifier>PMID: 37067802</identifier><language>eng</language><publisher>United States: American Medical Association</publisher><subject>Conflict of Interest ; Drug Industry ; Humans ; Infectious Diseases ; Medicine ; Online Only ; Research Letter</subject><ispartof>JAMA network open, 2023-04, Vol.6 (4), p.e238592-e238592</ispartof><rights>2023. This work is published under https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>Copyright 2023 Ahiskali AS et al. .</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-a471t-e734952fff2081059fc982b43702277f458de42a98e01d178f4a517decca07a53</citedby><cites>FETCH-LOGICAL-a471t-e734952fff2081059fc982b43702277f458de42a98e01d178f4a517decca07a53</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,780,784,885,27924,27925,37012,37013</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/37067802$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ahiskali, Aileen S</creatorcontrib><creatorcontrib>Drekonja, Dimitri M</creatorcontrib><creatorcontrib>Alpern, Jonathan D</creatorcontrib><title>Conflicts of Interest Among Infectious Diseases Clinical Practice Guideline Authors and the Pharmaceutical Industry</title><title>JAMA network open</title><addtitle>JAMA Netw Open</addtitle><description>This cross-sectional study assesses the prevalence of conflicts of interest (COI) associated with guideline-recommended drugs among Infectious Diseases Society of America clinical practice guideline authors and compliance with the Council on Medical Specialty Societies and Institute of Medicine guidelines.</description><subject>Conflict of Interest</subject><subject>Drug Industry</subject><subject>Humans</subject><subject>Infectious Diseases</subject><subject>Medicine</subject><subject>Online Only</subject><subject>Research Letter</subject><issn>2574-3805</issn><issn>2574-3805</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><recordid>eNpdUU1PXCEUJU2baqx_ocF0082MfApvZSZj1UlM6qJdE-RdHKbvwRR4Nv57Gb9iZQOXe87JvecgdETJnBJCjzd2tBHqv5T_pC3EOSOMz7Xs2Ae0z6QSM66J_PjmvYcOS9kQQhihvDuRn9EeV-REacL2UVmm6IfgasHJ41WskKFUvBhTvG2lB1dDmgo-CwVsgYKXQ4jB2QFfZ9t6DvDFFHpov4AXU12nXLCNPa5rwNdrm0frYKqPjFXsp1Lz_Rf0yduhwOHzfYB-n__4tbycXf28WC0XVzMrFK0zUFx0knnvGdGUyM67TrMb0YZnTCkvpO5BMNtpILSnSnthJVU9OGeJspIfoNMn3e10M0LvINZsB7PNYbT53iQbzP-dGNbmNt0ZSmg7SjWF788KOf2dmjFmDMXBMLQEmiuGNQ8F40yLBv32DrpJU45tP8Mp14IqqWhDdU8ol1MpGfzrNJSYXbzmXbxmF6_Zxdu4X9-u88p8CZM_AEsgp7g</recordid><startdate>20230403</startdate><enddate>20230403</enddate><creator>Ahiskali, Aileen S</creator><creator>Drekonja, Dimitri M</creator><creator>Alpern, Jonathan D</creator><general>American Medical Association</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>K9.</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20230403</creationdate><title>Conflicts of Interest Among Infectious Diseases Clinical Practice Guideline Authors and the Pharmaceutical Industry</title><author>Ahiskali, Aileen S ; Drekonja, Dimitri M ; Alpern, Jonathan D</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a471t-e734952fff2081059fc982b43702277f458de42a98e01d178f4a517decca07a53</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Conflict of Interest</topic><topic>Drug Industry</topic><topic>Humans</topic><topic>Infectious Diseases</topic><topic>Medicine</topic><topic>Online Only</topic><topic>Research Letter</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ahiskali, Aileen S</creatorcontrib><creatorcontrib>Drekonja, Dimitri M</creatorcontrib><creatorcontrib>Alpern, Jonathan D</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>JAMA network open</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ahiskali, Aileen S</au><au>Drekonja, Dimitri M</au><au>Alpern, Jonathan D</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Conflicts of Interest Among Infectious Diseases Clinical Practice Guideline Authors and the Pharmaceutical Industry</atitle><jtitle>JAMA network open</jtitle><addtitle>JAMA Netw Open</addtitle><date>2023-04-03</date><risdate>2023</risdate><volume>6</volume><issue>4</issue><spage>e238592</spage><epage>e238592</epage><pages>e238592-e238592</pages><issn>2574-3805</issn><eissn>2574-3805</eissn><abstract>This cross-sectional study assesses the prevalence of conflicts of interest (COI) associated with guideline-recommended drugs among Infectious Diseases Society of America clinical practice guideline authors and compliance with the Council on Medical Specialty Societies and Institute of Medicine guidelines.</abstract><cop>United States</cop><pub>American Medical Association</pub><pmid>37067802</pmid><doi>10.1001/jamanetworkopen.2023.8592</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2574-3805
ispartof JAMA network open, 2023-04, Vol.6 (4), p.e238592-e238592
issn 2574-3805
2574-3805
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10111177
source Publicly Available Content Database (Proquest) (PQ_SDU_P3)
subjects Conflict of Interest
Drug Industry
Humans
Infectious Diseases
Medicine
Online Only
Research Letter
title Conflicts of Interest Among Infectious Diseases Clinical Practice Guideline Authors and the Pharmaceutical Industry
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T21%3A28%3A56IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Conflicts%20of%20Interest%20Among%20Infectious%20Diseases%20Clinical%20Practice%20Guideline%20Authors%20and%20the%20Pharmaceutical%20Industry&rft.jtitle=JAMA%20network%20open&rft.au=Ahiskali,%20Aileen%20S&rft.date=2023-04-03&rft.volume=6&rft.issue=4&rft.spage=e238592&rft.epage=e238592&rft.pages=e238592-e238592&rft.issn=2574-3805&rft.eissn=2574-3805&rft_id=info:doi/10.1001/jamanetworkopen.2023.8592&rft_dat=%3Cproquest_pubme%3E2802423284%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-a471t-e734952fff2081059fc982b43702277f458de42a98e01d178f4a517decca07a53%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=3138417571&rft_id=info:pmid/37067802&rfr_iscdi=true